期刊文献+

应用受试者曲线分析血栓弹力图在老年人群阿司匹林抵抗诊断中的价值 被引量:10

Role of thromboelastography in diagnosis of aspirin resistance in the elderly
下载PDF
导出
摘要 目的应用ROC曲线评价血栓弹力图在诊断阿司匹林抵抗(AR)方面的价值。方法收集2008年4月~2010年7月驻京部队干休所服用阿司匹林(75~100mg/d,≥1个月)的老年患者471例。所有患者行光比浊法和血栓弹力图法检测血小板的功能。其光比浊法AR诊断标准为:花生四烯酸(AA)作诱导剂,血小板聚集率≥20%。结果采用AA诱导光比浊法,AR患者65例,发生率13.8%。以经典光比浊法为参照,通过ROC曲线发现,血栓弹力图法曲线下面积为0.794(0.755~0.830)。采用血栓弹力图法诊断AR,血小板聚集率临界点为56.2%,特异性为79.6%,敏感性为73.8%。无论是采用血小板聚集率≥56.2%,或传统的≥50%的临界点为血栓弹力图法诊断AR的标准,与AA诱导的光比浊法比较,在诊断AR方面,二者一致性较差(Kappa〈0.7)。结论血栓弹力图法在诊断AR方面,不完全与光比浊法诊断AR结果相符。因此,对血栓弹力图结果的解读需要谨慎。 Objective To assess the role of thromboelastography(TEG)in diagnosis of aspirin resistance(AR)according to its ROC curve.Methods Four hundred and seventy-one elderly patients in Beijing who administered aspirin(75-100 mg/d)≥ 1 month from April 2008 to July2010were included in this study.Their platelet function was tested by turbidimetry and TEG respectively.AR was diagnosed when arachidonic acid(AA)-induced platelet aggregation rate was≥20%.Results AR was diagnosed in 65patients(13.8%)by turbidimetry.TEG showed that the area under the ROC curve was 0.794(0.755-0.830).The critical platelet aggregation rate was56.2%.The specificity and sensitivity of TEG for AR were 79.6% and 73.8% respectively.AR could thus be diagnosed by TEG whether the critical platelet aggregation rate was ≥56.2% or the traditional platelet aggregation rate was≥50%.The consistency was poor between TEG and turbidimetry in diagnosis of AR(Kappa0.7).Conclusion TEG is not quite consistent with turbidimetry in diagnosis of AR.It should thus be careful to diagnose AR according to TEG.
出处 《中华老年心脑血管病杂志》 CAS 2015年第12期1265-1267,共3页 Chinese Journal of Geriatric Heart,Brain and Vessel Diseases
基金 国家自然科学基金(81300252)
关键词 ROC曲线 血栓弹力描记术 阿司匹林 花生四烯酸 血小板聚集 ROC curve thrombelastography aspirin arachidonic acid platelet aggregation
  • 相关文献

参考文献8

  • 1李晓利,范利,曹剑,王强,刘霖,胡国梁,胡亦新,王亚真,武若君.不同实验方法调查431例老年患者阿司匹林抵抗患病率[J].中南大学学报(医学版),2012,37(4):338-342. 被引量:15
  • 2Mahla E,Tantry US,Gurbel PA.Platelet function testing before CABG is recommended in the guidelines:but do we have enough Evidence?J Interv Cardiol,2015,28:233-235.
  • 3Paniccia R,Priora R,Liotta AA,et al.Platelet function tests:a comparative review.Vasc Health Risk Manag,2015,11:133-148.
  • 4Patrono C.Role of clinical pharmacology in the development of antiplatelet drugs.Clin Ther,2014,36:2096-2111.
  • 5Carroll RC,Craft RM,Snider CC,et al.A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.Anesth Analg,2013,116:282-286.
  • 6Chesnutt JK,Han HC.Effect of red blood cells on platelet activation and thrombus formation in tortuous arterioles.Front Bioeng Biotechnol,2013,1:18.
  • 7Passacquale G,Vamadevan P,Pereira L,et al.Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes.PLoS One,2011,6:e25595.
  • 8Kuzniatsova N,Shantsila E,Lip GY,et al.The membrane expression of P-selectin,but not monocyte-platelet aggregates,is influenced by variability in response to aspirin in patients with coronary artery disease.Platelets,2014,25:142-143.

二级参考文献1

共引文献14

同被引文献84

  • 1杜昂鹰,张家文,唐磊,余美佳.妇科恶性肿瘤患者术后生存质量调查[J].中国实用妇科与产科杂志,2007,23(3):198-200. 被引量:27
  • 2Barnett HJ ,Taylor DW, Eliasziw M, et al. Benefit of carotid endarter- ectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collabora- tors[ J]. N Engl J Med,1998,339(20) :1415-1425.
  • 3Clinical alert:benefit of carotid endarterectomy for patients with high- grade stenosis of the internal carotid artery. National Institute of Neu- rological Disorders and Stroke Stroke and Trauma Division. North A- merican Symptomatic Carotid Endarterectomy Tiial (NASCET) in- vestigators [ J ]. Stroke, 1991,22 ( 6 ) : 816-817.
  • 4Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterecto- my for treatment of carotid-artery stenosis [ J ]. N Engl J Med,2010, 363 ( 1 ) : 11-23.
  • 5Doig D,Turner EL, Dobson J, et al. Predictors of stroke, myocardial infarction or death within 30 days of carotid artery stenting: results from the international carotid stenting study [ J ]. Eur J Vasc Endovasc Surg,2016,51 (3) :327-334.
  • 6Gensicke H,van der Worp HB, Nederkoorn PJ, et al. Ischeinic brain lesions after carotid artery stenting increase future cerebrovascular risk[J]. J Am Coil Cardiol,2015,65(6) :521-529.
  • 7Gori AM, Grifoni E, Valenti R, et al. High on-aspirin platelet reactivi- ty predicts cardiac death in acute coronary syndrome patients under- going PCI[J]. Eur J Intern Med,2016.
  • 8Patti G, Nusca A, Mangiacapra F, et al. Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients un- dergoing percutaneous coronary intervention results of the ARMY- DA-PRO ( Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study[ J]. J Am Coil Cardiol,2008,52(14) :1128-1133.
  • 9Jhang KM,Huang JY, Nfor ON, et al. Is extended duration of dual antiplatelet therapy after carotid stenting beneficial [ J ]. Medicine (Baltimore) ,2015,94 (40) : e1355.
  • 10Verzini F. Commentary on predictors of stroke, myocardial infarc- tion, or death within 30 days of carotid artery stenting: results fromthe international carotid stenting study. An old story (Not for Old Patients) [J].Eur J Vasc Endovasc Surg,2016,51 (3) :335.

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部